This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
NMI Holdings (NMIH) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
NMI Holdings (NMIH) delivered earnings and revenue surprises of 15.38% and 2.11%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
5 Insurance Stocks' Q2 Earnings Coming Up: What to Expect
by Sushmita Sarker
Here, we take a look at five insurance stocks, ACGL, AXS, NMIH, UNM and VOYA, set to report earnings results on Jul 30.
Why NMI Holdings (NMIH) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
NMI Holdings (NMIH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why NMI Holdings (NMIH) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
RenaissanceRe (RNR) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
RenaissanceRe (RNR) delivered earnings and revenue surprises of 14.06% and 0.82%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
NMI Holdings (NMIH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
NMI Holdings (NMIH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why NMI Holdings (NMIH) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Reasons Why Investors Should Retain Sun Life (SLF) Stock Now
by Zacks Equity Research
Sun Life (SLF) stands to benefit from strategic investments in Asia, strengthening asset management businesses, the scale-up of its U.S. operations and a strong financial position.
Why You Should Stay Invested in Arch Capital (ACGL) Stock
by Zacks Equity Research
Arch Capital (ACGL) remains poised to gain from new business opportunities, rate improvement, favorable estimates and a solid capital position.
Aflac (AFL), SKYGEN Team Up to Enhance Dental and Vision Services
by Zacks Equity Research
Aflac (AFL) joins forces with SKYGEN to improve dental and vision benefit management, boosting customer satisfaction and AFL's product sales through advanced technology and streamlined processes.
Arthur J. Gallagher (AJG) Buys Cleary Benefits, Spurs Portfolio
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of Cleary Benefits is set to enhance its benefits consulting capabilities and expand its operations in the northeast region.
Reasons Why Investors Should Consider Buying RLI Stock Now
by Zacks Equity Research
RLI stands to gain from a compelling product portfolio, rise in rate, improved retention, higher premium receipts, sufficient liquidity and effective capital deployment.
NMIH or CB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NMIH vs. CB: Which Stock Is the Better Value Option?
Should You Retain Trupanion (TRUP) Stock in Your Portfolio?
by Zacks Equity Research
Trupanion (TRUP) gains from a focus on pet health and well-being in the pet insurance market. Its solid balance sheet supports investment in new product development and international expansion.
EverQuote (EVER) Rallies 220% in a Year: What's Driving It?
by Zacks Equity Research
EverQuote (EVER) rallies on the back of higher consumer traffic, solid performance of automotive and other insurance marketplace verticals, favorable growth estimates and solid capital position.
Why You Should Hold American International (AIG) Stock Now
by Zacks Equity Research
American International (AIG) is expected to benefit from rising premiums in the General Insurance business, improving investment income, enhanced savings from AIG Next, and streamlining initiatives.
Here's Why You Should Hold Brighthouse Financial (BHF) Now
by Zacks Equity Research
Brighthouse Financial (BHF) gains from higher annuity and life insurance sales, conservative investment strategy, improved interest rates and effective capital deployment.
Here's Why Hold Strategy is Apt for CNA Financial (CNA) Stock
by Zacks Equity Research
CNA Financial (CNA) remains poised to grow on the back of strong rate, higher income from limited partnership, improved net earned premium and sufficient liquidity.
Allstate (ALL) Rises 45% in a Year: Evaluating the Road Ahead
by Zacks Equity Research
Allstate (ALL) remains well-poised for growth on higher P&C insurance premiums, strategic acquisitions and cost-cutting initiatives.
Should You Add NMI Holdings (NMIH) Stock for Better Returns?
by Zacks Equity Research
NMI Holdings (NMIH) is set to grow on an improving mortgage insurance portfolio, higher new insurance written volume, a comprehensive reinsurance program and a solid capital position.
Here's Why NMI Holdings (NMIH) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should You Retain Progressive (PGR) Stock in Your Portfolio?
by Zacks Equity Research
Progressive (PGR) is poised to grow from its compelling portfolio, leadership position, strength in Vehicle and Property businesses, healthy policies in force, retention and a solid capital position.
MetLife (MET), GeoBlue Unveil Globaline for Expatriate Benefits
by Zacks Equity Research
MetLife (MET) and GeoBlue launch Globaline, a comprehensive expatriate benefits solution, offering unified medical and ancillary coverage, leveraging extensive global health networks for seamless support.